Kairos Pharma (KAPA) Return on Assets (2024 - 2025)
Kairos Pharma's (KAPA) quarterly Return on Assets came in at 0.01% in Q4 2025, little changed YoY from 0.01% in Q4 2024, and up 5.93% on a QoQ basis from 0.01% in Q2 2025.
Kairos Pharma (KAPA) Return on Assets (2024 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 2 years of Return on Assets data on file, last reported at 0.01% in Q4 2025.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Assets improved to 0.01% in Q4 2025, from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q4 2024 to a low of 0.01% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Kairos Pharma | 5.39 Mn | 55,970.58 | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |